These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 27042816)
1. Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: a retrospective analysis in 1307 patients aged ≥ 50 years. Teulings HE; Ceylan E; Overkamp M; Vrijman C; Bos JD; Nijsten TE; Wolkerstorfer A; Luiten RM; van der Veen JP Br J Dermatol; 2016 Oct; 175(4):821-4. PubMed ID: 27042816 [No Abstract] [Full Text] [Related]
2. High prevalence of autoimmune thyroiditis in children and adolescents with vitiligo. Kroon MW; Vrijman C; Chandeck C; Wind BS; Wolkerstorfer A; Luiten RM; Bos JD; Geskus RB; van Trotsenburg P; van der Veen JP Horm Res Paediatr; 2013; 79():137-44. PubMed ID: 23548513 [TBL] [Abstract][Full Text] [Related]
3. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners. Teulings HE; Overkamp M; Ceylan E; Nieuweboer-Krobotova L; Bos JD; Nijsten T; Wolkerstorfer AW; Luiten RM; van der Veen JP Br J Dermatol; 2013 Jan; 168(1):162-71. PubMed ID: 23136900 [TBL] [Abstract][Full Text] [Related]
4. Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study. Ingordo V; Cazzaniga S; Raone B; Digiuseppe MD; Musumeci ML; Fai D; Pellegrino M; Pezzarossa E; Di Lernia V; Battarra VC; Sirna R; Patrizi A; Naldi L Dermatology; 2014; 228(3):240-9. PubMed ID: 24603479 [TBL] [Abstract][Full Text] [Related]
5. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan. Chen YT; Chen YJ; Hwang CY; Lin MW; Chen TJ; Chen CC; Chu SY; Lee DD; Chang YT; Liu HN J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1362-9. PubMed ID: 25510261 [TBL] [Abstract][Full Text] [Related]
6. Vitiligo and associated autoimmune disease: retrospective review of 300 patients. Sawicki J; Siddha S; Rosen C J Cutan Med Surg; 2012; 16(4):261-6. PubMed ID: 22784519 [TBL] [Abstract][Full Text] [Related]
7. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Iacovelli P; Sinagra JL; Vidolin AP; Marenda S; Capitanio B; Leone G; Picardo M Dermatology; 2005; 210(1):26-30. PubMed ID: 15604541 [TBL] [Abstract][Full Text] [Related]
8. Profile of vitiligo patients attending a training and research hospital in Central Anatolia: a retrospective study. Gönül M; Cakmak SK; Oğuz D; Gül U; Kiliç S J Dermatol; 2012 Feb; 39(2):156-9. PubMed ID: 21955223 [TBL] [Abstract][Full Text] [Related]
9. Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families. Narita T; Oiso N; Fukai K; Kabashima K; Kawada A; Suzuki T Allergol Int; 2011 Dec; 60(4):505-8. PubMed ID: 21778811 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of vitiligo patients with versus without associated autoimmune thyroid disease. Ma Z; Cao P; Cai M; Lin Q; Long X; Ge M; Yu J; He S; Yu J; Zhang J Int J Dermatol; 2024 Apr; 63(4):491-496. PubMed ID: 38108619 [TBL] [Abstract][Full Text] [Related]
11. Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation pattern. Ezzedine K; Diallo A; Léauté-Labrèze C; Seneschal J; Mossalayi D; AlGhamdi K; Prey S; Bouchtnei S; Cario-André M; Boralevi F; Jouary T; Taieb A Arch Dermatol; 2012 Apr; 148(4):497-502. PubMed ID: 22508876 [TBL] [Abstract][Full Text] [Related]
12. [Polyglandular autoimmune syndrome type II: epidemiology and forms of manifestation]. Förster G; Krummenauer F; Kühn I; Beyer J; Kahaly G Dtsch Med Wochenschr; 1999 Dec; 124(49):1476-81. PubMed ID: 10629665 [TBL] [Abstract][Full Text] [Related]
13. Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. Uncu S; Yaylı S; Bahadır S; Okten A; Alpay K Int J Dermatol; 2011 Feb; 50(2):175-9. PubMed ID: 21244381 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of vitiligo and associated comorbidities in Korea. Lee H; Lee MH; Lee DY; Kang HY; Kim KH; Choi GS; Shin J; Lee HJ; Kim DH; Kim TH; Lee AY; Lee SC; Lee S; Kim KW; Hann SK; Park CJ; Oh SH Yonsei Med J; 2015 May; 56(3):719-25. PubMed ID: 25837178 [TBL] [Abstract][Full Text] [Related]
15. Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea. Bae JM; Lee JH; Yun JS; Han B; Han TY J Am Acad Dermatol; 2017 May; 76(5):871-878. PubMed ID: 28238453 [TBL] [Abstract][Full Text] [Related]
16. Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: a prospective observational study. Mazereeuw-Hautier J; Bezio S; Mahe E; Bodemer C; Eschard C; Viseux V; Labreze C; Plantin P; Barbarot S; Vabres P; Martin L; Paul C; Lacour JP; J Am Acad Dermatol; 2010 Jun; 62(6):945-9. PubMed ID: 20466172 [TBL] [Abstract][Full Text] [Related]
17. Vitiligo and associated autoimmune disorders: a retrospective hospital-based study in Mumbai, India. Poojary SA Allergol Immunopathol (Madr); 2011; 39(6):356-61. PubMed ID: 21474231 [TBL] [Abstract][Full Text] [Related]
19. Vitiligo and thyroid dysfunction in children and adolescents. Prćić S; Djuran V; Katanić D; Vlaški J; Gajinov Z Acta Dermatovenerol Croat; 2011; 19(4):248-54. PubMed ID: 22185925 [TBL] [Abstract][Full Text] [Related]
20. Effect of age at onset on disease characteristics in vitiligo. Kanwar AJ; Mahajan R; Parsad D J Cutan Med Surg; 2013; 17(4):253-8. PubMed ID: 23815958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]